Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Issue 1 (January 2019)
- Record Type:
- Journal Article
- Title:
- Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Issue 1 (January 2019)
- Main Title:
- Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
- Authors:
- Hackl, Monika
Eycken, Elizabeth Van
Henau, Kris
Dimitrova, Nadya
Sekerija, Mario
Dušek, Ladislav
Mägi, Margit
Malila, Nea
Leinonen, Maarit
Velten, Michel
Troussard, Xavier
Bouvier, Veronique
Guizard, Anne-Valérie
Bouvier, Anne-Marie
Arveux, Patrick
Maynadié, Marc
Woronoff, Anne-Sophie
Robaszkiewicz, Michel
Baldi, Isabelle
Monnereau, Alain
Tretarre, Brigitte
Colonna, Marc
Molinié, Florence
Bara, Simona
Schvartz, Claire
Lapôtre-Ledoux, Bénédicte
Grosclaude, Pascale
Stabenow, Roland
Luttmann, Sabine
Nennecke, Alice
Engel, Jutta
Schubert-Fritschle, Gabriele
Heidrich, Jan
Holleczek, Bernd
Jónasson, Jón Gunnlaugur
Clough-Gorr, Kerri
Comber, Harry
Mazzoleni, Guido
Giacomin, Adriano
Sardo, Antonella Sutera
Barchielli, Alessandro
Serraino, Diego
De Angelis, Roberta
Mallone, Sandra
Tavilla, Andrea
Pierannunzio, Daniela
Rossi, Silvia
Santaquilani, Mariano
Knijn, Arnold
Pannozzo, Fabio
Gennaro, Valerio
Benfatto, Lucia
Ricci, Paolo
Autelitano, Mariangela
Spagnoli, Gianbattista
Fusco, Mario
Usala, Mario
Vitale, Francesco
Michiara, Maria
Tumino, Rosario
Mangone, Lucia
Falcini, Fabio
Ferretti, Stefano
Angela Filiberti, Rosa
Marani, Enza
Iannelli, Arturo
Sensi, Flavio
Piffer, Silvano
Gentilini, Maria
Madeddu, Anselmo
Ziino, Antonio
Maspero, Sergio
Candela, Pina
Stracci, Fabrizio
Tagliabue, Giovanna
Rugge, Massimo
Trama, Annalisa
Gatta, Gemma
Botta, Laura
Capocaccia, Riccardo
Pildava, Santa
Smailyte, Giedre
Calleja, Neville
Johannesen, Tom Børge
Rachtan, Jadwiga
Góźdź, Stanisław
Błaszczyk, Jerzy
Kępska, Kamila
de Lacerda, Gonçalo Forjaz
Bento, Maria José
Miranda, Ana
Diba, Chakameh Safaei
Almar, Enrique
Larrañaga, Nerea
de Munain, Arantza Lopez
Torrella-Ramos, Ana
Díaz García, José María
Marcos-Gragera, Rafael
Sanchez, Maria Josè
Navarro, Carmen
Salmeron, Diego
Moreno-Iribas, Conchi
Galceran, Jaume
Carulla, Marià
Mousavi, Mohsen
Bouchardy, Christine
Ess, Silvia M.
Bordoni, Andrea
Konzelmann, Isabelle
Rashbass, Jem
Gavin, Anna
Brewster, David H.
Huws, Dyfed Wyn
Visser, Otto
Bielska-Lasota, Magdalena
Primic-Zakelj, Maja
Kunkler, Ian
Benhamou, Ellen
Imbimbo, Martina
Maury, Jean-Michel
Garassino, Marina
Girard, Nicolas
… (more) - Abstract:
- Abstract: The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality careAbstract: The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of databases, translational research programs, and clinical trials. Access to innovative strategies represents a major challenge, as there is a lack of funding for clinical research in rare cancers and their rarity precludes the design of robust clinical trials that could lead to specific approval of drugs. In this context, patient-centered initiatives, such as the establishment of dedicated networks, are warranted. International societies, such as IMIG (International Mesothelioma Interest Group) and ITMIG (International Thymic Malignancy Interest Group) provide infrastructure for global collaboration, and there are many advantages to having strong regional groups working on the same issues. There may be regional differences in risk factors, susceptibility, management and outcomes. The ability to address questions both regionally as well as globally is ideal to develop a full understanding of mesothelioma and thymic malignancies. In Europe, through the integration of national networks with EURACAN, the collaboration with academic societies and international groups, the development of networks in thoracic oncology provides multiplex integration of clinical care and research, ultimately ensuring equal access to high quality care to all patients, with the opportunity of conducting high level clinical and translational research projects. … (more)
- Is Part Of:
- European journal of surgical oncology. Volume 45:Issue 1(2019)
- Journal:
- European journal of surgical oncology
- Issue:
- Volume 45:Issue 1(2019)
- Issue Display:
- Volume 45, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 45
- Issue:
- 1
- Issue Sort Value:
- 2019-0045-0001-0000
- Page Start:
- 75
- Page End:
- 80
- Publication Date:
- 2019-01
- Subjects:
- Oncology -- Periodicals
Cancer -- Surgery -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Cancérologie -- Périodiques
Oncologie
Chirurgie (geneeskunde)
Electronic journals
Electronic journals -- Sciences
Electronic journals -- Medicine
Electronic journals
616.994059005 - Journal URLs:
- http://www.ejso.com/ ↗
http://www.sciencedirect.com/science/journal/07487983 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/07487983 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0748-7983;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/cgi-bin/links/toc/ejso ↗ - DOI:
- 10.1016/j.ejso.2018.01.078 ↗
- Languages:
- English
- ISSNs:
- 0748-7983
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.745500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9277.xml